Tegretol 200 mg and 400 mg Tablets, Divitabs, Suspension
PDF Leaflet Revision Date: 07 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Epilepsy, bipolar disorder, trigeminal neuralgia.
Dosage (summary)
Adults: 100-200 mg once/twice daily, increase to 400 mg 2-3 times daily. Max 1600 mg/day.
Onset of Action / Duration
Onset: 30 mins, Duration: 12-24 hours
Special Populations
- Elderly
- Children
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Risk of fetal harm; avoid breastfeeding.
Key Drug Interactions
- CYP3A4 inducers/inhibitors
- Hormonal contraceptives
- MAOIs
Contraindications
- Hypersensitivity
- AV block
- Bone-marrow depression
- Porphyria
- SJS/TEN history
Common side effects
- Dizziness
- Drowsiness
- Nausea
- Allergic skin reactions
Counselling Points
- Monitor for skin reactions
- Avoid abrupt withdrawal
- Use effective contraception
Serious warnings
- Serious skin reactions
- Hematological effects
- Suicidal ideation
Important Disclaimer
The Tegretol 200 mg and 400 mg Tablets, Divitabs, Suspension professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
